The Leadership Team at DeuteRx is responsible for setting the company's strategic vision and guiding its mission to enhance racemic drugs through innovative approaches like Deuterium-Enabled Chiral Switching (DECS). They oversee research and early development initiatives, ensure alignment with regulatory standards, and foster collaboration within the organization to drive advancements in biopharmaceuticals that benefit patients.
View all